GlassScriptPhysician profile
Colin Sanner
NPI 1558377879
$2,073.68
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $456 · 2021: $722.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $636.94 | 2019 | |
| Biogen, INC. | $324.45 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $170.51 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $155.14 | 2019-2021 | |
| Amgen INC. | $113.17 | 2019-2021 | |
| Lilly USA, LLC | $73.45 | 2019-2021 | |
| Allergan, INC. | $72.72 | 2020 | |
| Abbvie INC. | $67.75 | 2021 | |
| Ucb, INC. | $66.41 | 2021 | |
| Sk Life Science, INC. | $45.17 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $39.04 | 2019-2021 | |
| Dynasplint Systems INC. | $34.67 | 2021 | |
| Lundbeck LLC | $34.06 | 2019 | |
| Portola Pharmaceuticals, LLC | $32.48 | 2019 | |
| Emd Serono, INC. | $25.63 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $23.45 | 2020 | |
| Mallinckrodt Hospital Products INC. | $22.57 | 2021 | |
| Zyla Life Sciences, INC. | $20.13 | 2020 | |
| Sunovion Pharmaceuticals INC. | $18.84 | 2020 | |
| Genzyme Corporation | $17.96 | 2020 | |
| Acadia Pharmaceuticals INC | $17.86 | 2021 | |
| Avanir Pharmaceuticals, INC. | $16.76 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.46 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.01 | 2021 | |
| Mdd US Operations, LLC | $14.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Sanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.